LINC-PINT Inhibited Malignant Progression of Bladder Cancer by Targeting miR-155-5p.

Han, Xiancheng; Liu, Jing; Liu, Yongguo; Mou, Linkai; Li, Chunlong.

Afiliação

Han X; Department of Urology, Affiliated Hospital of Weifang Medical University, Weifang, Shandong, 261031, People's Republic of China.
Liu J; Department of Pathology, Weifang Traditional Chinese Hospital, Weifang, Shandong, 261041, People's Republic of China.
Liu Y; Department of Urology, Affiliated Hospital of Weifang Medical University, Weifang, Shandong, 261031, People's Republic of China.
Mou L; Department of Urology, Affiliated Hospital of Weifang Medical University, Weifang, Shandong, 261031, People's Republic of China.
Li C; Department of Urology, Affiliated Hospital of Weifang Medical University, Weifang, Shandong, 261031, People's Republic of China.

Cancer Manag Res ; 13: 4393-4401, 2021.

Article em En | MEDLINE | ID: mdl-34103994